Weight Gain After Orthotopic Liver Transplantation: Is Nonalcoholic Fatty Liver Disease Cirrhosis a Risk Factor for Greater Weight Gain?

被引:19
|
作者
Kouz, Jasmine [1 ]
Vincent, Catherine [2 ]
Leong, Aaron [1 ]
Dorais, Marc [3 ]
Raekel, Agnes [4 ]
机构
[1] McGill Univ, Royal Victoria Hosp, Dept Med, Div Endocrinol,Hosp Ctr, Montreal, PQ H3A 1A1, Canada
[2] Univ Montreal, Dept Med, Div Hepatol, St Luc Hosp,Hosp Ctr, Montreal, PQ H3C 3J7, Canada
[3] StatSciences Inc, Notre Dame Ille Perrot, PQ, Canada
[4] Univ Montreal, Ctr Hosp, Div Endocrinol, Dept Med,St Luc Hosp, Montreal, PQ H2X 3J4, Canada
关键词
OBESE-PATIENTS; STEATOHEPATITIS; SURVIVAL; RECIPIENTS; IMPACT; OVERWEIGHT; EXERCISE; OUTCOMES;
D O I
10.1002/lt.23951
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Posttransplant weight gain is common after orthotopic liver transplantation. We sought to determine the extent of weight gain at 5 years after transplantation in patients with nonalcoholic fatty liver disease (NAFLD) cirrhosis versus patients with other types of cirrhosis (non-NAFLD). We studied 126 liver transplants performed between 2005 and 2007 at Saint Luc Hospital, University of Montreal. Seventeen of the 126 patients (13.5%) had NAFLD cirrhosis. Ascites volume was difficult to assess, so we used the body mass index (BMI) at 3 months as the reference BMI. All patients gained weight after transplantation, but BMI increased significantly more and earlier among the NAFLD patients [4.8 versus 1.5 kg/m(2) at 1 year (P = 0.001), 5.0 versus 2.3 kg/m(2) at 2 years (P = 0.01), and 5.6 versus 2.6 kg/m(2) at 5 years (P = 0.009)] in comparison with non-NAFLD patients in unadjusted analyses. The greatest BMI increase over time was investigated with univariate and multivariate logistic regression analyses. The BMI increase was divided into tertiles for each period of time observed. The greatest BMI increase over time was defined as the top tertile of BMI increase. After adjustments for potential confounders (ie, total cholesterol, diabetes, and length of hospital stay), NAFLD was no longer associated with a risk of a greater BMI increase [odds ratio (OR) = 3.73 at 1 year (P = 0.11), OR = 2.15 at 2 years (P = 0.34), and OR = 2.87 at 5 years (P = 0.30)]. These findings suggest the need for multidisciplinary, early, and close weight monitoring for all patients. All patients could benefit from pretransplant counseling regarding weight gain and its consequences. (C) 2014 AASLD.
引用
收藏
页码:1266 / 1274
页数:9
相关论文
共 50 条
  • [31] Association of adult weight gain and nonalcoholic fatty liver in a cross-sectional study in Wan Song Community, China
    Zhang, W. -J.
    Chen, L. -L.
    Zheng, J.
    Lin, L.
    Zhang, J. -Y.
    Hu, X.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2014, 47 (02) : 151 - 156
  • [32] Prevalence and Severity of Nonalcoholic Fatty Liver Disease Among Caregivers of Patients With Nonalcoholic Fatty Liver Disease Cirrhosis
    Siddiqui, Mohammad Shadab
    Carbone, Salvatore
    Vincent, Robert
    Patel, Samarth
    Driscoll, Carolyn
    Celi, Francesco S.
    Billingsley, Hayley
    Rotelli, Brando
    John, Binu
    Potere, Nicola
    Viscusi, Michele
    Adiletta, Veronica
    Sanyal, Arun J.
    Luketic, Velimir A.
    Reichman, Trevor
    Bhati, Chandra S.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (10) : 2132 - 2133
  • [33] Weight Change and the Development of Nonalcoholic Fatty Liver Disease in Metabolically Healthy Overweight Individuals
    Cho, In Young
    Chang, Yoosoo
    Sung, Eunju
    Kang, Jae-Heon
    Shin, Hocheol
    Wild, Sarah H.
    Byrne, Christopher D.
    Ryu, Seungho
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (03) : E583 - E599
  • [35] Diet, Weight Loss, and Liver Health in Nonalcoholic Fatty Liver Disease: Pathophysiology, Evidence, and Practice
    Marchesini, Giulio
    Petta, Salvatore
    Dalle Grave, Riccardo
    HEPATOLOGY, 2016, 63 (06) : 2032 - 2043
  • [36] Liver Transplantation in Recipients With Class III Obesity: Posttransplant Outcomes and Weight Gain
    Soma, Daiki
    Park, Yujin
    Mihaylov, Plamen
    Ekser, Burcin
    Ghabril, Marwan
    Lacerda, Marco
    Chalasani, Naga
    Mangus, Richard S.
    Kubal, Chandrashekhar A.
    TRANSPLANTATION DIRECT, 2022, 8 (02): : E1242
  • [37] Recurrent Disease Following Liver Transplantation for Nonalcoholic Steatohepatitis Cirrhosis
    Malik, Shahid M.
    deVera, Michael E.
    Fontes, Paulo
    Shaikh, Obaid
    Sasatomi, Eizaburo
    Ahmad, Jawad
    LIVER TRANSPLANTATION, 2009, 15 (12) : 1843 - 1851
  • [38] Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation
    Younossi, Zobair M.
    Marchesini, Giulio
    Pinto-Cortez, Helena
    Petta, Salvatore
    TRANSPLANTATION, 2019, 103 (01) : 22 - 27
  • [39] Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis
    Caussy, Cyrielle
    Soni, Meera
    Cui, Jeffrey
    Bettencourt, Ricki
    Schork, Nicholas
    Chen, Chi-Hua
    Al Ikhwan, Mahdi
    Bassirian, Shirin
    Cepin, Sandra
    Gonzalez, Monica P.
    Mendler, Michel
    Kono, Yuko
    Vodkin, Irine
    Mekeel, Kristin
    Haldorson, Jeffrey
    Hemming, Alan
    Andrews, Barbara
    Salotti, Joanie
    Richards, Lisa
    Brenner, David A.
    Sirlin, Claude B.
    Loomba, Rohit
    JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (07): : 2697 - 2704
  • [40] Physical activity support or weight loss counseling for nonalcoholic fatty liver disease?
    Montesi, Luca
    Caselli, Chiara
    Centis, Elena
    Nuccitelli, Chiara
    Moscatiello, Simona
    Suppini, Alessandro
    Marchesini, Giulio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (29) : 10128 - 10136